Medical Device Investing T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
